Objective To find useful indices to identify subjects at high risk for developing diabetes. Glucose0 and Glucose60. 
Introduction

There is a worldwide epidemic of type 2 diabetes the prevalence of diabetes for all age groups worldwide was estimated at 2.8% in 2000 and 4.4% in 2030, along with an increasing prevalence of obesity (1). Diabetes affects both quality of life and medical expenditures for treating diabetes itself and its complications, including cardiovascular disease (2). Thus, preventing diabetes can both preserve individual health and control the socioeconomic burden of the disease.
A cost-effective approach to preventing diabetes requires identification of subjects at high risk for developing diabetes, e.g., through measurement of insulin resistance and/or secretion, the main pathogenic feature of diabetes (3, 4) . Insulin resistance indices include fasting insulin (5) , homeosta-
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Non-progressors (n=178) No sis model assessment of insulin resistance (HOMA-IR) (6) , and the Matsuda insulin sensitivity index (MISI) (7) , as well as the insulinogenic index for insulin secretion (8) . The insulin secretion / insulin resistance index (ISIRI), a product of MISI and the insulinogenic index, has also been proposed (9) . Many indices, such as fasting insulin (10) (11) (12) , HOMA-IR (11, 12) , the insulinogenic index (10) (11) (12) , and ISIRI (9) are associated with the subsequent risk of diabetes, but there is little data comparing them. 
We have developed the novel index "Insulin Response Ratio (IRR)", the ratio of plasma insulin levels early after oral glucose loading to fasting insulin. We hypothesized that this index could also evaluate the risk of developing diabetes because it reflects both insulin resistance and insulin secretion, with a lower value resulting from high fasting insulin, which indicates insulin resistance, and/or a reduced insulin response after glucose loading due to deficient insulin secretion. We also evaluated the usefulness of fasting plasma glucose (Glucose0), glucose level at 60 minutes (Glucose60) during a 75-g oral glucose tolerance test (OGTT), and hemoglobin A1C (HbA1C) for the prediction of diabetes in order to clarify whether indices for insulin resistance and/or secretion can provide information in addition to these conventional examinations for identifying higher risk subjects for diabetes mellitus. Thus, we sought to identify predictive indices for patients at high risk of developing type 2 diabetes.
Methods
Subjects and baseline data collection
Follow-up data collection
Progression to diabetes was assessed using the records of these repeated OGTT surveys based on the 1999 Japanese criteria (13) (1980-85, 1986-91 or 1992-97) , years of interval between the first and the follow- Data are mean ± standard deviation or number (%)
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OGTT, 75g-oral glucose tolerance test
All subjects had recorded values for at least one OGTT survey accompanied by insulin measurements and were confirmed not to have diabetes from 1980 to 1997 in Nishikawa town, Japan. The followed subjects had also recorded values for at least one repeated OGTT in a subsequent year during 1981 to 2001 whereas non-followed subjects had no record of repeated OGTT.
* Based on the 1998 criteria of the World Health Organization. † A parent or a sibling had diabetes mellitus ‡ Number of valid cases were 173 in the followed subjects and 229 in the non-followed subjects. 
Results
Characteristics in the first OGTT survey were compared between the 230 subjects that were followed for type 2 diabetes (followed subjects; i.e. 52 progressors and 178 nonprogressors) and the 295 non-diabetic subjects that were not followed (non-followed subjects) ( Table 1) . Age (p<0.001), BMI (p<0.001) and HbA1C (p<0.001) were significantly higher in the followed subjects than in the non-followed subjects. Familial history of diabetes also tended to be more prevalent in the followed subjects although it was not statistically significant (p=0.063). The followed subjects were significantly more likely to be IFG or IGT than the nonfollowed subjects (p<0.001). The term of the first OGTT survey tended to be earlier in the followed subjects than in the non-followed subjects (p=0.011). In the calculation of following indices, "mg/dL" was used as a unit of glucose and "μU/mL", as a unit of insulin. , hemoglobin A ; Glucose 0 , fasting glucose; Glucose 60 , glucose at 60 minutes during OGTT; Insulin 0 , fasting insulin; other abbreviations, described in footnotes of Table 3 Data are categorized into two values using the median values for all the subjects that appeared in Table 3 as the cutoff points, and ORs and 95% CIs of the high (>median) or *the low(<median) categories were calculated using logistic regression analyses.
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Discussion
In the present study, Glucose0, Glucose60 and almost all indices for insulin resistance and/or secretion were associated with the risk of progression to type 2 diabetes even af-
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Minimum adjustment model adjusted for age, sex, term of the first OGTT, years of interval between the first and the follow-up OGTTs, and change in body mass index during the follow-up.
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Odds ratios and 95% confidence intervals were calculated in the minimum adjustment model which adjusted for age, sex, term of the first OGTT, years of interval between the first and the follow-up OGTTs, and change in body mass index during the follow-up. , Glucose >100mg/dL and Glucose >188mg/dL NGT, normal glucose tolerance; IFG, impaired fasting glucose and IGT, impaired glucose tolerance; based on the 1998 World Health Organization criteria Data are number of progressors / number of followed subjects in upper line, and odds ratio (95% confidence interval)
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Odds ratios and 95% confidence intervals were calculated in the minimum adjustment model which adjusted for age, sex, term of the first OGTT, years of interval between the first and the follow-up OGTTs, and change in body mass index during the follow-up. 
